Internationally indexed journalInternationally indexed journal · Siddha system was developed by...

13
Internationally indexed journal Internationally indexed journal Internationally indexed journal Internationally indexed journal Indexed in Chemical Abstract Services (USA), Index coppernicus, Ulrichs Directory of Periodicals, Google scholar, CABI ,DOAJ , PSOAR, EBSCO , Open J gate , Proquest , SCOPUS , EMBASE ,etc. . .. Rapid and Easy Publishing Rapid and Easy Publishing Rapid and Easy Publishing Rapid and Easy Publishing The “International Journal of Pharma and Bio Sciences” (IJPBS) is an international journal in English published quarterly. The aim of IJPBS is to publish peer reviewed research and review articles rapidly without delay in the developing field of pharmaceutical and biological sciences www.ijpbs.net Indexed in Elsevier Bibliographic Database (Scopus and EMBASE) SCImago Journal Rank 0.288 Impact factor 2.958*

Transcript of Internationally indexed journalInternationally indexed journal · Siddha system was developed by...

Internationally indexed journalInternationally indexed journalInternationally indexed journalInternationally indexed journal Indexed in Chemical Abstract Services (USA), Index coppernicus, Ulrichs Directory of Periodicals, Google scholar, CABI ,DOAJ , PSOAR, EBSCO , Open J gate , Proquest , SCOPUS , EMBASE ,etc.

.

..

Rapid and Easy PublishingRapid and Easy PublishingRapid and Easy PublishingRapid and Easy Publishing The “International Journal of Pharma and Bio Sciences” (IJPBS) is an international journal in English published quarterly. The aim of IJPBS is to publish peer reviewed research and review articles rapidly

without delay in the developing field of pharmaceutical and biological sciences

www.ijpbs.net

Indexed in Elsevier Bibliographic Database

(Scopus and EMBASE)

SCImago Journal Rank 0.288

Impact factor 2.958*

Elsevier

Chemical Abstracts Service (www.cas.org)

SNIP value – 0.77

SJR - 0.288

IPP - 0.479

SNIP – Source normalised impact per pSJR – SCImago Journal rank IPP –Impact per publication Source –www.journalmetrics.com (Powered by scopus (ELSEVIER)

ISSN

evier Bibliographic databas

(Scopus & Embase)

CODEN IJPBJ2

er paper

And indexed/catalogued in many more university

*Instruction to Autho

For any Queries, v

ISSN 6299 -0975

tabases

n

Authors visit www.ijpbs.net

ries, visit “contact” of www.ijpbs.net

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 566

Research Article Pharmacognosy

International Journal of Pharma and Bio Sciences ISSN 0975-6299

CHARACTERIZATION OF A SIDDHA DRUG (PŨRNA CANTIROTAYA CENTŨRAM): AN APPROACH TO STANDARDIZATION

CHITRA B1*, RAMASWAMY RS2 AND SHAKILA R3

1

National Institute of Siddha, Sanatorium, Chennai-600 047, Tamil Nadu, India. 2

Central Council for Research in Siddha, Arignar Anna Hospital Campus, Arumbakkam,

Chennai-600106, Tamil Nadu, India. 3

Siddha Central Research Institute, Arignar Anna Hospital Campus, Arumbakkam,

Chennai-600106, Tamil Nadu, India.

ABSTRACT

Siddha system of medicine is existing among the indian society since time immemorial. However, in spite of their efficacy, they have been widely criticized due to lack of standardization and their complex preparation methods. The present study was designed as a step towards standardization of the herbo-metallic formulation, Pũrna Cantirotaya Centũram (PCC). To assure the quality of PCC, the drug was subjected to

physico-chemical parameters as mentioned in PLIM guidelines, X‑Ray Diffraction

(XRD) and Scanning Electron Microscopy (SEM) and Energy Dispersive analysis of X-ray (EDAX). The SEM study revealed that the particles in the formulation are agglomerated. The particle size varied between 1 and 10 µm. EDAX study indicated that the drug contains mercury, sulphur, gold, sodium, potassium, calcium, carbon and oxygen in major percentage and magnesium, aluminium, silicon, iron and niobium in minor percentage. It is concluded that PCC is a complex compound, having very small particle size and essential elements that might be the reason for its wide ranging clinical efficacy. KEYWORDS: Kaya karpa drug, tuberculosis, thathuporul karpam, rejuvenator, lingam, mercury and sulphur.

*Corresponding author

CHITRA B National Institute of Siddha, Sanatorium, Chennai-600 047, Tamil Nadu, India.

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 567

INTRODUCTION

The rennaisance of Herbal medicines, with possible treatment for many health problems have led to increase in the safety concerns regarding the drug usage. According to WHO, 80% of world population are opting for herbal drugs for major health care1. Siddha system was developed by the Siddhars, the ancient spiritual saints of India. It had been taught through oral tradition and being the lifestyle of the South Indian people from centuries ago. Siddha system laid emphasis on the healthier lifestyle through a holistic approach. In siddha medicine, metals like gold, silver, mercury, minerals such as sulphur, mica, arsenic, zinc and several other gems, shells, horns are treated with herbs and are given as white calx (Parpams) and red calx (Centũrams). Centũram is prepared by the process of sublimation2. Pũrna Cantirotaya Centũram (PCC) is a formulation prepared from Gold, Mercury and Sulphur in the ratio of 1:8:16. It is indicated for bronchitis, asthma, rat bite, tuberculosis, anaemia, dropsy, constipation, fever, dysentery, diarrhoea, lancinating pain, leucorrhea, impotency, infertility, skin diseases3. It improves the sperm count. It acts as a nervine tonic. It is one of the thathuporul karpam, i.e. mineral rejuvenator drug4. Siddha vaithiyars used mercury not only to cure innumerable diseases, but also to rejuvenate the body and promote longevity. Although longer used in medicine, it was used once as a purgative treatment in syphilis5. Mercury (II) complexes with 2-formylpyridinethio-semicarbazone showed good anti-amoebic activity6 and their complexes with isatin-3-thiosemicarbazone showed good antimicrobial activity7. Siddha system has five forms of mercury viz., mercury metal-rasam, red sulphide of mercury-lingam, mercuric chloride- veeram, mercury sub-chloride (mercurous chloride)-pooram and red oxide of mercury-rasa chenduram8. Pharmaceutical literatures in Siddha system never insisted to use raw liquid mercury for therapeutic purposes. Ancient Siddha practitioners were experts in converting inorganic substances into nano and ionic form,

known as Alchemy (Rasavaatham) which is more reactive and readily absorbed by the human cells9. Alchemical process is said to be the most critical but significant method that transform the low quality metals like lead into noble metals such as gold etc., for the management of chronic diseases. By impregnating and triturating with organic material, like juices, decoctions of herbs etc., they are made homologous to the tissue cells, their toxicity is reduced and acceptability to the cell is increased. During this process, certain organic and inorganic materials are added to mercury, which helps to increase its medicinal efficacy and safety. Mercury if taken in crude form it is lethal, but when properly purified and processed it is converted into noble drug10. The method of processing mercury for therapeutic purposes is known as rasa suthi in Siddha system of medicine8. In Siddha tradition, it is used in combination with sulphur. An easy bond making with the metal ions i.e. the reactivity of sulphur makes it unique to act as a precursor in the preparation of Centũram11. The addition of sulphur is to control the fluidity of mercury and converts into mercuric sulphide, which is insoluble in mineral acids. Sulphur is a laxative, enhances bile juice secretion, alterative, antiseptic and diaphoretic. It is excreted through duct glands like sweat, urine, mammary glands. It enhances secretions of skin, bronchioles and rectum. Sulphur is mainly used therapeutically in eighteen types of leucoderma, flatulence, hepatomegaly, ascites, gastric ulcer, eye diseases, poisonous bites, chronic venereal diseases, rheumatic fever, diarrhoea and respiratory symptoms8. Gold plays an important role in diagnosis, microsurgery of the ear and therapeutic applications. After the nano gold synthesis, the research on therapeutic application has been increased. Gold is proposed for use in chronic rheumatoid arthritis and cancers. Studies have proved that combining gold nanoparticle with other anticancer drugs could possibly target cancer cells in breast cancer and AIDS related

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 568

Kaposi’s sarcoma12. Siddha literatures claim that gold formulations could be useful as rejuvenator, to delay the ageing process, to improve immunity especially in chronic disease conditions. The drug PCC needs expertise to prepare the drug appropriately. The preparation of PCC is given by Theraiyar and Thirumoolar siddhars. The special effects of the drug were dealt by Thirumoolar in his verse as if a person take this drug for his ailment, he not only get cured from the disease, but also he can live long without any disease, can avoid greying of hair and halt aging. The previous work in the same drug explored its content as mercuric sulphide and gold oxides. However, the exploration of its preparation method comprehensively dealt in the present study with the standardization of the final product

through physicochemical and analytical studies.

MATERIALS AND METHODS

Procurement and authentication of raw drugs The raw drugs of mercury and sulphur were purchased from an authentic raw drug store in Chennai. Gold was purchased from India Post as 24 carats. The above raw drugs were authenticated by the Chemist, Siddha central research institute, Chennai. The plant juices were collected from Herbal garden, National Institute of Siddha, Chennai. These plants were authenticated by Assistant professor (Botany), National Institute of Siddha, Chennai (Fig.1).

Figure 1 Showing Raw drugs for the preparation of PCC, Plantain stem pith, b) Red cotton flower,

c) 24 carat Gold Coins, d) Raw Mercury, e) Raw Sulphur.

Purification Process Purification and Stage wise preparation method with the photographs are given below: The raw materials were purified as mentioned in the Siddha literature as follows, Gold was made as

a thin foil by heat striking with rod repeatedly on it. Then it was coated with red soil (chemman) paste and dried .Then the foil was heat flared and washed .This process was repeated for six more times (Fig. 2).

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 569

Figure 2 Purification of gold; a) gold foil coated with red soil paste;

b) heat flaring of gold foil; c) gold after purification The mercury was ground with brick stone powder and turmeric powder, each for one hour. Then washed in pure water, boiled with Acalypha indica (kuppai meni) plant juice, until it vaporized (Fig. 3).

Figure 3 a) Mercury ground with brick powder, b) Mercury ground

with turmeric powder, c) Mercury after purification

i. The sulphur was taken with cow’s butter in an iron spatula, heated to melt and poured into Cow’s milk. This process was repeated for 30 times5 (Fig. 4).

Figure 4 a) Sulphur melting with butter ,b) melted sulphur poured into the milk, c) Sulphur after purification

Method of preparation Pũrna Cantirotaya Centũram (PCC) was prepared as per the method indicated in Siddha Vaidya Thirattu. The quantity of gold, mercury and sulphur for the preparation of PCC is given in Table 1. The purified gold foils and mercury (rasam) were ground together, and then sulphur (ganthagam) was added. Then the coarse black powder was triturated with the juice of red

cotton flower for two days (48 hours) consequently. The substance was allowed to dry. Then further triturated with the juice of plantain stem pith for another consecutive two days then made into pellets and dried (Fig. 5). Then the dried pellets were put in a mud vessel (kuppi) closed with mud plate and the junction was sealed with mud smeared cloth (Seelai mann) and allowed for complete drying. Then

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 570

the mud vessel was subjected to incineration by pudam with casurina logs. The heat process (Erippu thittam) was applied as three types namely Deepakkini (slow simple flame), Kamalakkini (medium flame) and Kaadaakkini (High flame), each for 12 hours continuously.

On the next day, after the mud kuppi cooled the seelai mann was carefully removed and the final product was collected and ground for one day to make homogeneously fine powder .The Centũram was stored in an airtight container3 (Fig. 6).

Figure 5 a) Mixture of gold, mercury and sulphur, b) Grinding with

redcotton flower juice, c) Grinding with plantain stem pith juice

Figure 6 a) Medicinal pellets containing mud vessel with seelaiman application before pudam,

b) Mud vessel after pudam, c) Erippu thittam , d) Final Centũram

Table 1 Raw drugs with composition

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 571

Siddha Properties Siddha specifications of Centũram were carried out as per the procedure given in the standard siddha text13,14. Physico-chemical Analysis The drug was subjected to physico-chemical

analysis such as loss on drying at 105⁰C, total ash, water soluble ash and acid insoluble ash as per the methods described in standard books14,15,16. X-Ray Diffraction spectra The XRD spectrum17 of PCC was recorded on a D8 ADVANCE model BRUKER make instrument. Cu K Alpha radiation was used for recording the spectra. The pattern was recorder from the angle 5 to 85 degree.

SEM-EDAX Analysis SEM-EDAX Analysis18 of PCC was investigated in a ZPISS, CARL MA15/EVO18 Scanning Electron Microscope hyphenated with EDAX.

RESULTS AND DISCUSSION

Siddha Properties of PCC The prepared PCC was initially tested on the parameters mentioned in standard Siddha texts. Bright red coloured PCC has no specific taste and odour. To check the fineness, on rubbing in between the thumb finger and index finger, it was fine enough to enter into creases of the finger. On sprinkling, it was floating on the surface of the static water taken in a bowl indicating its lightness. The Centũram was checked for any lusture in daylight and no lusture was observed. This is suggested by the test “absence of lusture” a quality to be looked for in the final product. The textual specification and inference are recorded in the Table 2.

Table 2 Siddha traditional standards as per PLIM Guidelines of Centũram

S.No Textual Specification Inference

1. Colour Bright red colour

2. Lusture Not Lustrous

3. In between the lines of the finger Entering into the finger prints while rubbing in between the index and thumb finger

4. Over the surface of water Floats

5. Odour Odorless

6. Taste Tasteless

Physico-chemical Parameters The loss on drying (LOD) indicates the moisture present in a drug under investigation. In this study, the LOD of PCC was calculated to be 0.699%, which is very less, it eventually designates its extensive shelf life. This confirms that Centũram retain their potency for 75 years as given in Siddha literature5. The total ash of PCC was determined as 38.60 %, which means that PCC contains 61.4 % of organic matter or decomposable inorganic

matter. Water-soluble ash was found to be 15.67 %. It may be due to the presence of soluble cations such as sodium, potassium and other anions. The acid insoluble ash value of 19.56 % reveals the content of hydrochloric acid insoluble metals and minerals, which may be gold in this case. The low value of the acid insoluble ash suggests the greater physiological availability of the drug. All the physico-chemical results are presented in Table3.

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 572

Table 3 Physico-chemical results of Pũrna Cantirotaya Centũram

S.No Physico-chemical Parameter Mean (n=2) ± SD

1. Loss on Drying at 105°C, % w/w 0.699±0.099

2. Total Ash, % w/w 38.60±0.22

3. Water soluble Ash, % w/w 15.76±0.11

4. Acid insoluble Ash, % w/w 19.56±0.10

X-Ray Diffraction spectra X-ray diffraction study of the final product did not give sharp peaks, indicating the loss of crystalline nature. Lack of crystallinity, i.e., amorphization, increased wettability and dispersibility and particle size reduction are considered to be important factors for dissolution rate enhancement19. The complete XRD pattern of PCC is shown in Fig. 7. The XRD pattern showing the peak of gold is shown in Fig. 8 and that of mercuric sulphide is shown in Fig. 9. Mercuric sulphide (marked as cinnabar) is the product, which has formed during the process. The study also revealed peaks of mercuric sulphide, gold in the final product. The formation of some different

compounds in the final product may be due to oxidation and reduction reaction of Au, Hg with sulfur in the presence of oxygen. In the process of PCC preparation, mercury is converted to its sulfide form in a major since the sulfur is an adjunct to the metal in the processing. During the heat treatment, some sulfides may be transformed to oxide. Because metallic sulfides when heated in air get converted to oxide of the metal and sulfur dioxide20. Therefore, some oxides of gold and mercury are also found in the PCC. Many metal oxides are toxic; in comparison, a sulfide of a metal is generally less toxic compared to its oxide or chloride, being relatively less soluble in body fluids21.

Figure 7 Complete XRD spectrum of PCC

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 573

Figure 8 XRD spectrum of PCC showing the peaks of gold

Figure 9 XRD spectrum of PCC showing mercuric sulphide peaks

SEM-EDAX Use of advanced analytical techniques is the highest need of time for the development of quality control parameters of the drug sample. Among them, SEM is the technique, which reveals the information on external morphology (texture), chemical composition and crystalline structure and orientation of materials making up the sample22. SEM analysis results (Fig.10) revealed that the particle size varies from 1 - 10 µm. As the preparation involves crunching of raw materials with herbal juices, heat processes and subsequent cooling of product, it tends to agglomerate the drug particles, which causes the particle size variation. Present study clearly depicted the role of every step of purification in removing the toxicity of minerals used and in

reducing the particle size and in converting the drug PCC into more nano-crystalline form, thus making the mineral preparation more biocompatible and contributed significantly in relieving the sufferings of ailing human society. The EDAX spectra showed the presence of 23.08% of mercury, 10.16% of sulphur, 20.18% carbon, 31.88% of oxygen, 3.5% of potassium, 2.32% of sodium, 2.77% of gold, 2.11% of calcium and other elements include magnesium (0.31%), iron (0.62%) sulphur (0.81%). The minor nutrients are responsible for the therapeutic action of the drug. The presence of calcium and magnesium was reported in the previous studies22. The EDAX spectrum is shown in Fig. 11 and the graphical representation in Fig. 12.

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 574

Figure 10 SEM images showing at different scales

Figure 11 EDAX graph showing various elements

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 575

Figure 12 Graphical representation of percentage of elements

CONCLUSION Pũrna Cantirotaya Centũram is a classical herbo-mineral formulation having great therapeutic benefit containing mercuric sulphide as the major component, gold in considerable amount and other micronutrients in minor quantities. It is evident that it contains gold; however, the percentage of gold varies from the earlier reports23. This difference could be justified only when different batches are prepared and studied under the same testing conditions.

ACKNOWLEDGEMENT Authors express their gratitude to Vaithiyar.Ravindranathan, Maduranthagam for helping in the drug preparation and thank Director, Siddha Central Research Institute, Arumbakkam, Chennai for facilities.

CONFLICT OF INTEREST Conflict of interest declared none.

REFERENCES

1. Shobhen R, Patel NM, Patel PM. A

reviewon modification of analytical techniques in herbal research. IJRAP, 2(5): 1483-1485, (2011).

2. Sudha A, Murty VS, Chandra TS. Standardization of Metal-Based Herbal Medicines. Am J Infect Dis, 5(3): 193-199, (2009).

3. Kuppuswami Mudaliyar KN, Uthamarayan KS. Siddha Vaidya Thirattu,1st Edn, Department of Indian Medicine and

Homeopathy publishers: Arumabakkam, Chennai, 153-154,(1998).

4. Thiagarajan SP. Sirappu Maruthuvam.1st Edn. Department of Indian Medicine and Homeopathy Publishers: Arumabakkam, Chennai,23-24, (1998).

5. Stwertka A. A guide to the elements. Rev. Edn, Oxford Univ. Press Inc: Perlin, USA,P.93, (1998).

6. Chandra S, Parmar S, Kumer Y. Synthesis, spectroscopic, and

Int J Pharm Bio Sci 2015 Jan; 6(1): (P) 566- 576

This article can be downloaded from www.ijpbs.net

P - 576

antimicrobial studies on bivalent zinc and mercury complexes of 2-formylpyridine thiosemicarbazone Bioinorg Chem Appl, 2009: Article ID 851316, 6 pages, (2009).

7. Konstantinović SS, Radova- nović BC, Sovilj SP, Stano- jević S. J Serb Chem Soc, 73(1): 7, (2008).

8. Thiagarajan R. Gunapaadam - Thathu Jeeva Vaguppu, 4th Edn. Department of Indian Medicine and Homeopathy publishers: Arumabakkam,Chennai, 167-220, (2004).

9. Patil YP, Pawar SH, Jadhav S, Kadu JS. Biochemistry of metal absorption in Human Body: Reference to check Impact of Nano Particles on Human Being. Int J Sci Res Pub, 3(4): 1-5, (2013).

10. Sathish R, Anbu J, Murugesan M, Anjana A, Kumar A. Toxicity study on siddha formulation Mega Sanjeevi Mathirai in albino rats. Int J Pharma Bio Sci, 3(3): 121-130, (2012).

11. Rajalakshmi P, Abeetha M, Devanathan R. Physicochemical analysis of gandhagam before and after purification. Int J Curr Pharm Res, 2(4): 32-35, (2010).

12. Panyala NR, Pena-Mendez EM, Havel J. Gold and nano-gold in medicine: overview, toxicology and perspectives. Journal of Ap-plied Biomedicine, 7: 75-91, (2009).

13. Anonymus.The Siddha Formulary of India, 1st Edn [Tamil version], Part-II, Govt. of India, Ministry of Health and Family Welfare. Department of Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homeopathy [AYUSH], New Delhi, (2011).

14. Lohar DR. Protocol For Testing Ayurvedic, Siddha & Unani Medicines. Pharmacopoeial Laboratory for Indian Medicine, AYUSH, Ministry of Health and Family Welfare, Government of India, Ghaziabad, p.31,(2011).

15. Anonymous. Quality Control Methods for Medicinal Plant Materials. Geneva: World Health Organization, 19, 20, 29-31, (1998).

16. Anonymous. Quality control methods for medicinal plants materials. Working document QAS/05.131/Rev.1. World Health Organization, Geneva, 27-38, (2005).

17. Cullity B D.Elements of X-ray Diffraction, 2nd Edn, Addison-Wesley Publishing Company, Inc., Reading, MA, (1978).

18. Goldstein J,Newbury DE,Joy DC. Scanning Electron Microscopy and X-ray Microanalysis, 3rd Edn, XIX, Springer Science: New York, 21-60, (2003).

19. Ganesh Chaulang, Piyush Patel, Sharwaree Hardikar, Mukul Kelkar, Ashok Bhosale, Sagar Bhise. Formulation and Evaluation of Solid Dispersions of Furosemide in Sodium Starch Glycolate. Tropical Journal of Pharmaceutical Research, February ; 8 (1): 43-51,(2009)

20. Hicks J.Comprehensive Chemistry, Rev. 2nd Edn, Macmillan India Ltd,New delhi, (1978).

21. Jagtap CY, Prajapati P, Patgiri B, Shukla VJ.Quality control parameters for Tamra (copper)Bhasma. Ancient Sci Life, 31(4): 164-70, (2012).

22. Kapoor RC. Some observations on the metal based preparation in the Indian System of Medicine. Indian J Trad Knowl, 9: 562-575, (2010).

23. Pathak YV, Lokhande JN. Handbook of Metallonutra ceuticals. Boca Raton: CRC Press, 111, (2014).

24. Austin A. Chemical characterization of a gold and mercury based Siddha Sasthric preparation – Poorna Chandrodayam. American Journal of Drug Discovery and Development, 2(3): 110-123, (2012).